Akoustis to Webcast Q1FY23 Results on November 14 at 8:00 am ET
Charlotte, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device...
Read moreCharlotte, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device...
Read moreBOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and...
Read moreCompany reports EPS of $2.80, Economic EPS of $4.21 in the third quarter of 2022 New...
Read moreCastellum, Inc. Announces Signing of LOI to Acquire $10 Million Government Contractor Castellum, Inc. (NYSE AMERICAN: CTM) announces the signing...
Read moreQ3 2022 net loss was $(0.27) per basic and diluted share and adjusted non-GAAP net income was $1.13 per basic...
Read moreIntuity Medical’s POGO Automatic® Blood Glucose Monitoring System Intuity Medical’s POGO Automatic® Blood Glucose Monitoring System is the only FDA-cleared...
Read moreTemecula, CA, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Global Warming Solutions, Inc. (OTC: GWSO), a global developer of green technologies...
Read moreVERVE-101 Investigational New Drug Application Placed on Hold by U.S. Food and Drug Administration Dosing Completed in First Dose Cohort...
Read moreStrong Revenue Growth; Commercial Aerospace Strength; Solid Gross MarginsSANTA ANA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE:...
Read moreEurope is expected to hold 21.2% market share for indoor location market. Professional services are expected to hold 55% market...
Read more